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Immunological challenge stimulates secretion of the pro-inflammatory cytokine interleukin
(IL)-6, resulting in variety of biological responses. In the gastrointestinal tract, IL-6 modulates
the excitability of submucosal neurons and stimulates secretion into the colonic lumen.
When considered in the context of the functional bowel disorder, irritable bowel syndrome
(IBS), where plasma levels of IL-6 are elevated, this may reflect an important molecular
mechanism contributing to symptom flares, particularly in the diarrhea-predominant phe-
notype. In these studies, colonic ion transport, an indicator of absorption and secretion, was
assessed in the stress-sensitiveWistar Kyoto (WKY) rat model of IBS. Mucosa-submucosal
colonic preparations fromWKY and control Sprague Dawley (SD) rats were mounted in Uss-
ing chambers and the basal short circuit current (ISC) was electrophysiologically recorded
and compared between the strains. Exposure to IL-6 (1 nM) stimulated a secretory current
of greater amplitude in WKY as compared to SD samples. Furthermore, the observed IL-
6-mediated potentiation of secretory currents evoked by veratridine and capsaicin in SD
rats was blunted in WKY rats. Exposure to IL-6 also stimulated an increase in transepithelial
resistance in both SD andWKY colonic tissue.These studies demonstrate that the neuroex-
citatory effects of IL-6 on submucosal plexi have functional consequences with alterations
in both colonic secretory activity and permeability. The IL-6-induced increase in colonic
secretory activity appears to neurally mediated. Thus, local increases in IL-6 levels and
subsequent activation of enteric neurons may underlie alterations in absorpto-secretory
function in the WKY model of IBS.
Keywords: capsaicin, veratridine, interleukin-6, irritable bowel syndrome,Wistar Kyoto, ussing chambers, electro-
physiology
INTRODUCTION
The functional gastrointestinal (GI) disorder, irritable bowel syn-
drome (IBS) is characterized by episodic bouts of abdominal pain,
bloating, and altered bowel habit including diarrhea, constipation,
or both. Although the pathophysiological changes underlying IBS
are still being investigated, stress has been attributed a role in the
initiation, exacerbation, and persistence of IBS symptom flares
(Lydiard et al., 1993; Spiller, 2004; Fitzgerald et al., 2008). Addi-
tionally, a growing body of data implicates local activation of gut
immune factors in the development and persistence of IBS symp-
toms (Quigley, 2006; O’Malley et al., 2011c). Mucosal biopsies
from IBS patients express higher levels of T-cells, lymphocytes, and
mast cells (Chadwick et al., 2002) and plasma samples from IBS
patients exhibit altered pro-inflammatory cytokine profiles (Mac-
sharry et al., 2008). Indeed, interleukin (IL)-6 has reproducibly
been found to be elevated in plasma samples from IBS patients
(Dinan et al., 2006, 2008; Liebregts et al., 2007; Clarke et al., 2009;
Scully et al., 2010; McKernan et al., 2011).
As yet, the mechanisms that link altered cytokine profiles
with the development of functional GI disorders such as IBS are
poorly understood. However, there is growing evidence that IBS
patients have altered GI permeability (Camilleri et al., 2012) and
most pro-inflammatory cytokines have the capacity to influence
intestinal epithelial permeability (Al-Sadi et al., 2009). Indeed,
the importance of cytokines in neuromuscular dysfunction in the
inflamed intestine has been demonstrated (Hurst et al., 1993; Ruhl
et al., 1994), thus, with particular relevance to post-infective IBS,
immunomodulation of enteric neurons by cytokines released from
within the GI milieu may be important in the persistence of IBS
symptomatology (Ruhl et al., 2001).
Increased IL-6 synthesis following administration of a
cholinesterase inhibitor has been correlated with increased
abdominal pain and bloating (Dinan et al., 2008) and IL-6 can
modulate mucosal ion transport and epithelial permeability, in
addition to enhancing cholinergically mediated neurotransmis-
sion in rodents (Natale et al., 2003). Moreover, both IL-1β and
IL-6 act as excitatory neuromodulators in a subset of myenteric
neurons via presynaptic inhibition of acetylcholine release (Kelles
et al., 2000). IL-6 has also been shown to suppress nicotinic and
noradrenergic neurotransmission in guinea-pig submucosal neu-
rons (Xia et al., 1999). Previous studies from our group have shown
expression of IL-6 receptors on a subset of rat colonic submucosal
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neurons. Exposure of these neurons to recombinant IL-6 results
in increases in intracellular calcium [(Ca2+)i] levels, which in turn
results in increased colonic secretion (O’Malley et al., 2011b).
The Wistar Kyoto (WKY) rat has been validated (Greenwood-
Van Meerveld et al., 2005; Gibney et al., 2010; O’Malley et al.,
2010a) as an appropriate pre-clinical model of IBS, displaying
increased visceral sensitivity to colorectal distension and enhanced
colonic motility and fecal output following exposure to a psy-
chological stressor (Gibney et al., 2010; O’Malley et al., 2010a).
Colonic morphology and goblet cell expression is also altered
in this rat (O’Malley et al., 2010a) and it exhibits evidence of
altered cytokine expression. Although plasma levels of IL-6 are
not different between WKY and SD rats (unpublished observa-
tion), mucosal scrapings from WKY colons contain higher levels
of IL-6 and excised WKY colons secrete more IL-6 than control
Sprague Dawley (SD) colons. Moreover, these secretions stim-
ulate calcium responses of greater amplitude in naïve submu-
cosal neurons than the SD secretions (O’Malley et al., 2011a).
These observations are comparable to studies carried out in the
maternal separation (MS) model of IBS where MS secretions
stimulated a larger response in submucosal neurons than con-
trol non-separated colonic secretions. Moreover, recombinant IL-6
was shown to stimulate an increase in secretory activity (O’Malley
et al., 2011b).
Evidence is mounting that IL-6 has neuromodulatory effects
that contribute to altered GI function, however it is currently
unclear whether these effects translate into functional changes.
The current studies use Ussing chamber electrophysiology to
investigate absorpto-secretory function in WKY rats following
exposure to IL-6 and compare these effects to the SD control strain,
which has normal GI function.
MATERIALS AND METHODS
ANIMALS
Sprague Dawley and WKY rats (200–250 g) purchased from
Harlan, UK were group-housed 4–6/cage and maintained on a
12/12 h dark-light cycle (08.00–20.00). All experiments were in
full accordance with the European Community Council Directive
(86/609/EEC) and the local University College Cork animal ethical
committee.
TISSUE PREPARATION
Distal segments of colon were excised from naïve SD or WKY
rats and maintained in ice-cold bubbled (95% O2/ 5% CO2)
Krebs saline consisting of (in mmol/L) NaCl, 117; KCl, 4.8;
CaCl2, 2.5; MgCl2, 1.2; NaHCO3, 25; NaH2PO4, 1.2; and d-
glucose, 11. Longitudinal and circular muscle layers were removed
to prepare a mucosa-submucosal preparation for Ussing cham-
ber electrophysiology as previously described (O’Malley et al.,
2011b).
USSING CHAMBER ELECTROPHYSIOLOGY
Mucosa-submucosal preparations of distal colon were mounted
in Ussing chambers (exposed area of 0.12 cm2) with 5 ml of Krebs
solution (95% O2/5% CO2, 37˚C) in the basolateral and luminal
reservoirs. Tissues were voltage-clamped at 0 mV using an auto-
matic voltage clamp (EVC 4000, World Precision Instruments,
Sarasota, FL, USA) and the short circuit current (I SC) required
to maintain the 0 mV potential was monitored as a recording of
the net active ion transport across the epithelium. Experiments
were carried out simultaneously in all chambers and connected to
a PC equipped with DataTrax II software (WPI). This software was
used to measure the peak response and resistance was calculated
using Ohms law.
Based on previous evaluations of the pro-secretory effects of IL-
6 in SD tissues (O’Malley et al., 2011b), it was determined that the
peak response to IL-6 occurred within 10 min of application. Thus,
this time point was used to compare the effects of IL-6 on secre-
tion in WKY versus SD rats. Following a period of stabilization
(30–60 min) and prior to addition of any reagents, transepithelial
resistance (TER) was measured. Another measurement of TER
was taken at the end of the experiment (60–90 min later) and
the difference (∆ resistance) between the two measurements was
calculated.
STATISTICS
The data are represented as mean values± the standard error of
the mean (SEM). Students’ t -test and one-way ANOVA with Neu-
mann Keuls post hoc test were used to compare groups. Two-way
ANOVA was used to analyze strain and treatment effects as inde-
pendent variables. p≤ 0.05 was considered significant. All exper-
iments were conducted in tissue taken from at least six different
animals.
RESULTS
IL-6 EVOKES INCREASED COLONIC SECRETION AND TRANSEPITHELIAL
RESISTANCE IN SD ANDWKY RATS
Electrophysiological Ussing chamber studies were used to com-
pare colonic transepithelial ion transfer and tissue resistance in
the stress-sensitive WKY rats with the widely used SD compara-
tor strain. Short circuit current (I SC) was measured and used as
an indicator of net ionic movement across the tissue. In control
colonic sections, not treated with IL-6, basal I SC was found to be
lower in WKY (n= 9) colonic sections as compared to SDs (n= 18,
p< 0.05, Figure 1A). However, TER, an indicator of colonic per-
meability, was not different between SD (n= 17) and WKY (n= 8,
p> 0.05, Figure 1B) tissues.
Previous studies in SD tissues determined that a peak increase
in colonic I SC was observed at ∼10 min during a 30 min applica-
tion of IL-6 (1 nM) to the serosal reservoir (O’Malley et al., 2011b).
Therefore, all measurements were taken at the 10 min timepoint
in both SD and WKY colons. Replicating our previous findings
(O’Malley et al., 2011b), IL-6 evoked a small increase in I SC in
SD controls (n= 23). Application of IL-6 to WKY tissue samples
(n= 9) also induced a secretory current. However, the amplitude
of the secretory response was larger in WKY tissues than SDs
(p= 0.07, Figure 1C).
The change in TER was calculated by comparing a measure-
ment of TER at the beginning and end of each experiment
(60–90 min). In control tissue, not exposed to IL-6, no change
was observed in TER in either SD or WKY rats (Figure 1D).
However, the continued presence of IL-6 stimulated a signifi-
cant increase in TER in both SD (12.6± 5.3Ω cm2, n= 18) and
WKY (27.8± 11.7Ω cm2, n= 6, p> 0.05, Figure 1D) tissues.
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FIGURE 1 | IL-6 modulates transepithelial current and resistance. (A)
The histograms illustrates basal short circuit current (ISC, µA cm2, SD:
n=18, WKY: n=9) and (B) transepithelial resistance (TER, Ω cm2, SD:
n=17, WKY: n=8) in distal colon segments from naïve Sprague Dawley
(SD) and Wistar Kyoto (WKY) rats. (C)The histograms and representative
trace shows the effect of basolaterally applied IL-6 (1 nM, measured 10 min
after application) on basal ISC (SD: n=23, WKY: n= 9). (D)This histogram
illustrates the change (∆) in tissue resistance over the course of the
experiment (60–90 min, SD: n= 18, WKY: n=6). Values=mean±SEM.
* Indicates p<0.05.
Two-way ANOVA analysis demonstrated a clear effect of the
IL-6 treatment on tissue resistance [F (1, 44)= 14.2, p< 0.001]
but there were not any strain differences or interaction between
the factors despite a trend toward a larger effect in the WKY
tissue.
IL-6 POTENTIATES VERATRIDINE-STIMULATED SECRETORY CURRENTS
IN SD BUT NOTWKY RATS
To assess differences in the sensitivity of neuronally mediated
colonic secretion between SD and WKY rats, the sodium chan-
nel activator, veratridine (10µM) was applied to the basolateral
reservoir. In non-stimulated colon samples no differences were
noted in the peak response to veratridine between SD (n= 19)
and WKY (n= 10, p> 0.05, Figures 2A,B) rats. In paired experi-
ments we found that exposure to IL-6 (1 nM, 30 min) potentiates
the secretory effects of veratridine in SD tissues when compared to
control non-stimulated samples (n= 15, p< 0.05), which is con-
sistent with previous findings (O’Malley et al., 2011b). However, in
WKY tissues, IL-6 exposure had no effect on veratridine-induced
currents (n= 10, p> 0.05, Figures 2A,B).
IL-6 POTENTIATES BETHANECHOL-STIMULATED SECRETORY
CURRENTS
To investigate strain differences in cholinergically mediated cur-
rents, the muscarinic receptor agonist, bethanechol (10µM) was
added to the basolateral chamber. The agonist evoked a rapid
biphasic current in control SD tissues (n= 12). The peak response
in WKY rats was comparable (n= 9, p> 0.05, Figures 3A,B).
The modulatory effects of IL-6 on the bethanechol response were
subsequently examined in both tissues. As we have previously
demonstrated (O’Malley et al., 2011b), IL-6 potentiated the evoked
bethanechol response in SD tissues (n= 12, p< 0.05). IL-6 also
enhanced bethanechol-evoked secretion in WKY tissues (n= 9,
p= 0.05, Figures 3A,B). Two-way ANOVA analysis demonstrated
a significant effect of IL-6 treatment [F (1, 38)= 5.4, p< 0.05], but
no differences in strain or any interaction between the factors was
identified.
Muscarinic acetylcholine receptors can be present on both
epithelial cells and neurons in the gut. To determine which cell type
excited by bethanechol were sensitive to the effects of IL-6, con-
trol experiments in SD tissues were carried out in the presence of
the sodium channel blocker, tetrodotoxin. In paired experiments
(n= 5 each), I SC in IL-6-treated (98.8± 22.4µA/cm2) and control
(104± 29.7µA/cm2) tissues following administration bethane-
chol in the presence of tetrodotoxin (100 nM, 15 min) were similar
(p> 0.05). These data indicate that the potentiating effect of IL-
6 on the bethanechol response appears to be mediated through
neuronal activation.
IL-6 POTENTIATES THE ANTI-SECRETORY PHASE OF
CAPSAICIN-STIMULATED SECRETORY CURRENTS IN SD BUT NOTWKY
RATS
Finally, the sensory nerve stimulant capsaicin was examined in
SD and WKY tissues. In control tissues, addition of capsaicin
(1µM) caused a rapid biphasic response as previously described
(Yarrow et al., 1991). The early secretory phase (phase I) was
comparable in both SD (n= 10) and WKY samples (n= 10,
p> 0.05, Figures 4A,B). In phase II, where capsaicin evokes
an anti-secretory current, I SC values in non-stimulated SD and
WKY tissues were also comparable (p> 0.05, Figures 4A,B). Pre-
treatment with IL-6 (1 nM, 30 min) did not affect I SC in phase
I in either SD (n= 11) or WKY (n= 7) colons such that they
remained comparable (p> 0.05, Figures 4C,D). However, IL-6
potentiated the capsaicin-evoked anti-secretory current in SD rats
but not WKY rats such that a significant difference was appar-
ent between the strains (p< 0.05, Figures 4C,D). Using two-way
ANOVA, a difference in strain is approaching significance in the
secretory phase [F (1, 36)= 3.7, p= 0.06] with no effect of IL-6
and no interaction. In the anti-secretory phase, a strain differ-
ence is also apparent [F (1, 31)= 7.7, p< 0.01] but there is no
effect of the treatment itself and no interaction between the
factors.
DISCUSSION
This series of electrophysiological studies builds on previous work
from our group in which we demonstrated the capacity of IL-6 to
directly stimulate a secretory current and decrease membrane per-
meability in colons from SD rats (O’Malley et al., 2011b). These
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FIGURE 2 |Veratridine-induced currents in Sprague Dawley (SD)
andWistar Kyoto (WKY) colons. (A) Representative traces illustrate
the secretory current (ISC) induced by exposure to veratridine (10µM)
in non-stimulated (con) SD (thin gray line, n= 7) and WKY (thin black
line, n=9) colonic sections and IL-6-stimulated SD (thick gray line,
n= 7) and WKY (thick black line, n=9) colonic sections. (B)The
histogram shows the pooled data. Values=mean±SEM. * Indicates
p<0.05.
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FIGURE 3 | Cholinergically driven currents in Sprague Dawley (SD) and
Wistar Kyoto (WKY) rats are altered by IL-6 exposure. (A)The
representative traces show bethanechol-induced increases in short circuit
current (ISC) in control (Con, thin gray line, n= 12) and IL-6-(1 nM) stimulated
(IL-6, thick gray line, n=12) SD colonic tissue. WKY traces are also included
for control (thin black line, n=9) and Il-6-stimulated (thick black line, n=9)
colonic tissues. (B) Histograms show the pooled data. Values=mean±SEM.
* Indicates p<0.05.
studies have investigated the effects of IL-6 on colonic secretory
and permeability parameters in WKY rats which exhibit several
markers of GI dysfunction and have been used as an animal model
of IBS. By comparing changes in colonic I SC and TER between the
strains, we have demonstrated that IL-6-induced changes in secre-
tory activity and colonic permeability differ in WKY rats, thereby
revealing a possible immune-mediated mechanism which could
contribute to the dysfunctional bowel activity described in this rat
(O’Malley et al., 2010a).
The WKY rat has been well characterized as a suitable pre-
clinical model of IBS (Gunter et al., 2000; Gosselin et al., 2009;
Gibney et al., 2010; O’Malley et al., 2010a). The GI dysfunc-
tion exhibited by the WKY rat includes an innate hypersen-
sitivity to visceral pain stimuli such as that induced by col-
orectal distension (Gibney et al., 2010) and altered defecation
patterns, particularly when exposed to stress (O’Malley et al.,
2010a). Expression of the stress-related peptide, corticotropin-
releasing factor (CRF) receptors are altered both in the colon
(O’Malley et al., 2010b) and centrally (O’Malley et al., 2011d)
in this strain. Given that amygdalar CRFR1 activation can
contribute to visceral hypersensitivity in WKY rats (Johnson
et al., 2012) these changes may have direct effects on the
IBS-like symptom profile. Moreover, colonic toll-like receptor
expression is also altered (McKernan et al., 2009) in this
strain.
With regard to their colonic secretory parameters, WKY rats
appear to display a pro-absorptive phenotype, which is thought to
be reliant on decreased epithelial cholinergic sensitivity (Hyland
et al., 2008). Under resting conditions we also observed this pro-
absorptive phenotype as indicated by lower I SC in the WKY rat
as compared to SD. Interestingly, this relationship is reversed
in the presence of IL-6, with a larger current being evoked
from the WKY colonic tissues. The mechanisms underlying this
secretory event are as yet unclear, however we have previously
determined that submucosal neurons prepared from WKY colons
display increased sensitivity to the neuroexcitatory effects of IL-
6 (O’Malley et al., 2011a). As submucosal neurons have been
attributed a primary role in regulating mucosal secretion and
absorption, IL-6-mediated neural activation of colonic secretion
may override the pro-absorptive phenotype regulated by epithe-
lial cholinergic activity at rest (Hyland et al., 2008). This change in
absorpto-secretory function would be consistent with the increase
in mucus secretion and stress-induced fecal output evident in these
animals (O’Malley et al., 2010a).
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FIGURE 4 | IL-6 alters capsaicin-induced currents in Sprague
Dawley (SD) andWistar Kyoto (WKY) rat colons. (A)The
representative traces illustrate the secretory (phase I) and
anti-secretory (phase II) responses to capsaicin (1µM) in control SD
(gray line, n=10) and WKY (black line, n=10) distal colons. (B)The
histogram illustrates the pooled data for changes in current (ISC). (C)
The traces are representative of capsaicin-evoked responses
following exposure to IL-6 (1 nM) in SD (n= 11) and WKY (n=7). (D)
The pooled data are plotted in a histogram. Values=mean±SEM. *
indicates p< 0.05.
To further assess the importance of neurally evoked changes in
secretion following application of IL-6 to the basolateral side of
the tissue, pharmacological stimulators were applied as previously
described (Julio-Pieper et al., 2010). Veratridine evokes neuronally
mediated secretory currents by depolarizing intrinsic neurons via
increased permeability through voltage-gated Na+ channels. This
secretory response is caused by a net increase in Cl− secretion
(Sheldon et al., 1990). Under control conditions the veratridine-
evoked responses were of similar amplitude in both SD and WKY
colonic tissues and unlike SD tissue (O’Malley et al., 2011b), IL-6
had no effect on currents evoked in WKY tissue. Veratridine has
been shown to stimulate the release of enteric neurotransmitters
such as substance P, VIP, (Belai and Burnstock, 1988) and acetyl-
choline (Yau et al., 1986). However, further investigation will be
required to determine the neurotransmitters underlying the IL-6-
induced modulation of veratridine-stimulated ion secretion in SD
rats. Evidently, this potentiating mechanism is not active in WKY
rats.
The contribution of the cholinergic system to IL-6 secretion has
been demonstrated in IBS patients (Dinan et al., 2008). Indeed,
activation of secretomotor neurons may underlie neurogenic
secretory diarrhea (Liebregts et al., 2007). In SD rats we provided
evidence that IL-6 exposure potentiated currents induced by the
muscarinic receptor agonist, bethanechol that were sensitive to
the sodium channel blocker, tetrodotoxin. This effect was intact in
WKY tissues as IL-6 similarly enhanced the bethanechol current.
Finally, currents evoked by activating transient receptor poten-
tial cation channels (TRPV1) were examined by exposing the
tissue to capsaicin. Capsaicin stimulates visceral afferent neurons
in the GI tract causing the subsequent release of nerve termi-
nal neuropeptides which in turn, stimulate mucosal electrolyte
transport and fluid secretion (Holzer et al., 1990; Vanner and Mac-
Naughton, 1995), motility (Takaki and Nakayama, 1989), mucus
secretion (Moore et al., 1996), and mucosal blood flow (Akiba
et al., 1999) in addition to playing a protective role in main-
taining mucosal integrity (Evangelista and Meli, 1989; Esplugues
et al., 1990; Holzer et al., 1990). Indeed, TRPV1 is increased in
inflammatory diseases of the GI tract (Yiangou et al., 2001) and
in patients with rectal hypersensitivity (Chan et al., 2003). Appli-
cation of capsaicin-evoked a large biphasic response in SD tissues
which was comprised of an initial secretory phase followed by a
larger more sustained anti-secretory phase consistent with previ-
ous studies (Yarrow et al., 1991). Interestingly, responses evoked by
capsaicin in WKY tissues did not have such distinct phases. Rather
than a small secretory response, there appeared to be a delay prior
to the longer-lasting anti-secretory event, possibly indicating a
balance between the two opposing mechanisms. Indeed, the dif-
ferences between the strains came into sharper focus following
addition of IL-6, which potentiated the anti-secretory phase in
SD tissues only. Thus, in SD GI tissue, IL-6 exposure enhances
the anti-secretory activity of afferent nerves whereas WKY rats
have lost this regulatory response to IL-6 which could underlie
the overall increased secretory activity in this strain. Moreover, the
extrinsic, afferent innervation of the GI tract conveys information
to the CNS that gives rise to the sensations of pain and discomfort.
Thus, the insensitivity of WKY rats to IL-6-evoked potentiation of
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the capsaicin anti-secretory response may also be important in the
increased sensitivity to visceral pain (Gibney et al., 2010).
Although the mechanisms of this effect require further elu-
cidation, it is feasible that low-grade inflammation in the WKY
rat may result in constant stimulation of capsaicin-sensitive nerve
terminals causing neurotransmitter depletion or that IL-6 directly
inhibits neurotransmitter release in these neurons. Alternatively,
altered sensitivity to stress may contribute to these observations.
CRF1 receptor antagonists alleviate visceral sensitivity in the WKY
rat (Greenwood-Van Meerveld et al., 2005) but evidence exists for
crosstalk between IL-6 and CRF (O’Malley et al., 2011c). There-
fore, alterations in stress-induced expression of CRF receptors
(O’Malley et al., 2010b; O’Malley et al., 2011d), may be linked
to the increase in IL-6 sensitivity observed in the WKY rats.
Tissue resistance was also measured in these animals as a marker
of membrane permeability and was found to be similar between
strains. Interestingly, IL-6 stimulated an increase in TER in both
strains. Changes in permeability can occur as a result of alter-
ations in the expression of tight junctions (Chen et al., 2010;
Martinez et al., 2012), dysbiosis of microbiota (Fukuda et al.,
2011) or through the increased presence of pro-inflammatory
cytokines (Arrieta et al., 2006). Furthermore, stress can contribute
to changes in permeability as has previously been demonstrated
in WKY rats (Saunders et al., 2002). Over the 90 min dura-
tion of these recordings, one possibility might be an increase
in mucus secretion evoked by IL-6, which could influence mem-
brane permeability. Indeed, we have previously observed increased
expression of goblet cell number in the WKY strain (O’Malley
et al., 2010a). We demonstrated that acute application of IL-6
increases TER, appearing to help maintain the integrity of the
epithelial cell layer in both SD and WKY rats. This is consistent
with one previous study (Wang et al., 2007). On the other hand,
chronic exposure to elevated IL-6 levels may result in increased
gut permeability (Hiribarren et al., 1993; Natale et al., 2003).
As mucosal levels of the pro-inflammatory cytokine, IL-6 are
elevated in WKY colons (O’Malley et al., 2011a), one might have
expected that continuous exposure to IL-6 would have resulted
in increased colonic permeability in this strain. However, TER at
rest is comparable between SD and WKY rats. This may indicate
that there are increased numbers of IL-6-containing cells in the
mucosa of WKY rats but not necessarily increased levels of IL-6
secretion.
At a functional level, these studies have demonstrated that
IL-6-evoked secretion is enhanced in WKY colons and this is
likely to be due to increased sensitivity of submucosal neurons
to the pro-inflammatory cytokine. We have provided evidence
that inhibition of the potentiating effect of IL-6 on capsaicin-
evoked anti-secretory currents is a likely contributor to the changes
in colonic secretion. These data further demonstrate the neu-
romodulatory effects of IL-6 in colonic function and provide
mechanistic evidence of how elevations in systemic IL-6 in IBS
patients could be a contributory factor in the pathophysiology of
the disorder.
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